Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Validating a Quality-of-Life Instrument for Allergic Contact Dermatitis.

Botto N, Raffi J, Trivedi M, Ramirez F, Allen IE, Chren MM.

Dermatitis. 2019 Sep/Oct;30(5):300-305. doi: 10.1097/DER.0000000000000515.

PMID:
31524758
2.

Assessment of Sleep Disturbances and Exhaustion in Mothers of Children With Atopic Dermatitis.

Ramirez FD, Chen S, Langan SM, Prather AA, McCulloch CE, Kidd SA, Cabana MD, Chren MM, Abuabara K.

JAMA Dermatol. 2019 May 1;155(5):556-563. doi: 10.1001/jamadermatol.2018.5641.

3.

Association of Atopic Dermatitis With Sleep Quality in Children.

Ramirez FD, Chen S, Langan SM, Prather AA, McCulloch CE, Kidd SA, Cabana MD, Chren MM, Abuabara K.

JAMA Pediatr. 2019 May 1;173(5):e190025. doi: 10.1001/jamapediatrics.2019.0025. Epub 2019 May 6.

4.

Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial.

Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, Gelfand JM, Wong DJ, Gibbons BM, Gibbons CM, Torres J, Steel AC, Wang EA, Clark CM, Singh S, Kornmehl HA, Wilken R, Florek AG, Ford AR, Ma C, Ehsani-Chimeh N, Boddu S, Fujita M, Young PM, Rivas-Sanchez C, Cornejo BI, Serna LC, Carlson ER, Lane CJ.

JAMA Netw Open. 2018 Oct 5;1(6):e183062. doi: 10.1001/jamanetworkopen.2018.3062.

5.

Effects of new keratinocyte carcinomas on skin-related quality of life: Results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.

Siegel JA, Beatson M, Chren MM, Weinstock MA; Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial group.

J Am Acad Dermatol. 2019 May;80(5):1458-1459. doi: 10.1016/j.jaad.2018.12.054. Epub 2019 Jan 11. No abstract available.

PMID:
30639882
6.

The Skindex-mini: a streamlined QOL measurement tool suitable for routine use in clinic.

Swerlick RA, Zhang C, Patel A, Chren MM, Chen S.

J Am Acad Dermatol. 2018 Dec 24. pii: S0190-9622(18)33109-8. doi: 10.1016/j.jaad.2018.12.035. [Epub ahead of print] No abstract available.

PMID:
30590072
7.

Creating a Partnership Between Dermatologists and Geriatricians-Reply.

Linos E, Chren MM, Covinsky K.

JAMA Dermatol. 2019 Jan 1;155(1):125-126. doi: 10.1001/jamadermatol.2018.3660. No abstract available.

PMID:
30484815
8.

Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial.

Armstrong AW, Ford AR, Chambers CJ, Maverakis E, Dunnick CA, Chren MM, Gelfand JM, Gibbons CM, Gibbons BM, Lane CJ.

J Invest Dermatol. 2019 May;139(5):1037-1044. doi: 10.1016/j.jid.2018.09.039. Epub 2018 Nov 24.

9.

Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.

Neugebauer R, Su KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM.

J Am Acad Dermatol. 2019 Apr;80(4):998-1005. doi: 10.1016/j.jaad.2018.11.024. Epub 2018 Nov 17.

PMID:
30458208
10.

Outcomes and Risk Factors in Patients with Multiple Primary Melanomas.

Nosrati A, Yu WY, McGuire J, Griffin A, de Souza JR, Singh R, Linos E, Chren MM, Grimes B, Jewell NP, Wei ML.

J Invest Dermatol. 2019 Jan;139(1):195-201. doi: 10.1016/j.jid.2018.07.009. Epub 2018 Jul 19.

PMID:
30031745
11.

Geriatric Dermatology-A Framework for Caring for Older Patients With Skin Disease.

Linos E, Chren MM, Covinsky K.

JAMA Dermatol. 2018 Jul 1;154(7):757-758. doi: 10.1001/jamadermatol.2018.0286. No abstract available.

12.

How data can deliver for dermatology.

Abuabara K, Asgari MM, Chen SC, Dellavalle RP, Kalia S, Secrest AM, Silverberg JI, Solomon JA, Weinstock MA, Wu JJ, Chren MM; Epidemiology Expert Research Group.

J Am Acad Dermatol. 2018 Aug;79(2):400-402. doi: 10.1016/j.jaad.2018.03.020. Epub 2018 Mar 21. No abstract available.

13.

Skin cancer prevention messages on Facebook: Likes, shares, and comments.

Nosrati A, Pimentel MA, Falzone A, Hegde R, Goel S, Chren MM, Eye R, Linos E, Pagoto S, Walkosz BJ.

J Am Acad Dermatol. 2018 Sep;79(3):582-585.e1. doi: 10.1016/j.jaad.2018.02.062. Epub 2018 Mar 5. No abstract available.

14.

Development of a Comprehensive Quality-of-Life Measure for Facial and Torso Acne.

McLellan C, Frey MP, Thiboutot D, Layton A, Chren MM, Tan J.

J Cutan Med Surg. 2018 May/Jun;22(3):304-311. doi: 10.1177/1203475418756379. Epub 2018 Jan 31.

PMID:
29383947
15.

A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis.

Neugebauer R, Levandoski KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM.

J Am Acad Dermatol. 2018 Apr;78(4):710-716. doi: 10.1016/j.jaad.2017.12.042. Epub 2017 Dec 24.

16.

All-cause mortality in patients with basal and squamous cell carcinoma: A systematic review and meta-analysis.

Wehner MR, Cidre Serrano W, Nosrati A, Schoen PM, Chren MM, Boscardin J, Linos E.

J Am Acad Dermatol. 2018 Apr;78(4):663-672.e3. doi: 10.1016/j.jaad.2017.11.026. Epub 2017 Nov 13. Review.

17.

Teens, Tweets, and Tanning Beds: Rethinking the Use of Social Media for Skin Cancer Prevention.

Falzone AE, Brindis CD, Chren MM, Junn A, Pagoto S, Wehner M, Linos E.

Am J Prev Med. 2017 Sep;53(3S1):S86-S94. doi: 10.1016/j.amepre.2017.04.027. Review.

18.

Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib.

Bhutani T, Abrouk M, Sima CS, Sadetsky N, Hou J, Caro I, Chren MM, Arron ST.

J Am Acad Dermatol. 2017 Oct;77(4):713-718. doi: 10.1016/j.jaad.2017.03.038. Epub 2017 Aug 2.

PMID:
28780365
19.

Types of Shade Vary in Protection Just Like Sunscreens.

Opene C, Chren MM, Linos E.

JAMA Dermatol. 2017 Oct 1;153(10):1070-1071. doi: 10.1001/jamadermatol.2017.1718. No abstract available. Erratum in: JAMA Dermatol. 2017 Oct 1;153(10):1072.

20.

A review of the impact of patch testing on quality of life in allergic contact dermatitis.

Ramirez F, Chren MM, Botto N.

J Am Acad Dermatol. 2017 May;76(5):1000-1004. doi: 10.1016/j.jaad.2016.12.011. Review. No abstract available.

PMID:
28411766
21.

Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria.

Stuart SE, Schoen P, Jin C, Parvataneni R, Arron S, Linos E, Boscardin WJ, Chren MM.

J Am Acad Dermatol. 2017 Jun;76(6):1131-1138.e1. doi: 10.1016/j.jaad.2016.12.045. Epub 2017 Mar 29.

22.

Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision.

Nosrati A, Berliner JG, Goel S, McGuire J, Morhenn V, de Souza JR, Yeniay Y, Singh R, Lee K, Nakamura M, Wu RR, Griffin A, Grimes B, Linos E, Chren MM, Grekin R, Wei ML.

JAMA Dermatol. 2017 May 1;153(5):436-441. doi: 10.1001/jamadermatol.2016.6138.

23.

Comparing the Quality of Ambulatory Surgical Care for Skin Cancer in a Veterans Affairs Clinic and a Fee-For-Service Practice Using Clinical and Patient-Reported Measures.

Dizon MP, Linos E, Arron ST, Hills NK, Chren MM.

PLoS One. 2017 Jan 31;12(1):e0171253. doi: 10.1371/journal.pone.0171253. eCollection 2017.

24.

Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study.

Siegel JA, Chren MM, Weinstock MA; Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group.

J Am Acad Dermatol. 2016 Sep;75(3):639-642. doi: 10.1016/j.jaad.2016.05.008. No abstract available.

PMID:
27543222
25.

Research that Guides Clinical Decisions.

Chren MM, Arron ST.

J Invest Dermatol. 2016 Aug;136(8):1535-1537. doi: 10.1016/j.jid.2016.04.031.

26.

Skin Cancer in U.S. Elderly Adults: Does Life Expectancy Play a Role in Treatment Decisions?

Linos E, Chren MM, Stijacic Cenzer I, Covinsky KE.

J Am Geriatr Soc. 2016 Aug;64(8):1610-5. doi: 10.1111/jgs.14202. Epub 2016 Jun 15.

27.

Competing Risk of Death in Kaplan-Meier Curves When Analyzing Subsequent Keratinocyte Cancer-Reply.

Wehner MR, Linos E, Boscardin WJ, Chren MM.

JAMA Dermatol. 2016 Apr;152(4):494-5. doi: 10.1001/jamadermatol.2015.5153. No abstract available.

PMID:
27074364
28.

Association of Skin Cancer and Indoor Tanning in Sexual Minority Men and Women.

Mansh M, Katz KA, Linos E, Chren MM, Arron S.

JAMA Dermatol. 2015 Dec 1;151(12):1308-1316. doi: 10.1001/jamadermatol.2015.3126.

PMID:
26444580
29.

Online Advertising for Cancer Prevention: Google Ads and Tanning Beds.

Cidre Serrano W, Chren MM, Resneck JS Jr, Aji NN, Pagoto S, Linos E.

JAMA Dermatol. 2016 Jan;152(1):101-2. doi: 10.1001/jamadermatol.2015.3998. No abstract available.

PMID:
26444220
30.

Point: Care of potential low-risk basal cell carcinomas (BCCs) at the end of life: The key role of the dermatologist.

Linos E, Berger T, Chren MM.

J Am Acad Dermatol. 2015 Jul;73(1):158-61. doi: 10.1016/j.jaad.2015.02.005. No abstract available.

31.

Early detection of melanoma: reviewing the ABCDEs.

American Academy of Dermatology Ad Hoc Task Force for the ABCDEs of Melanoma, Tsao H, Olazagasti JM, Cordoro KM, Brewer JD, Taylor SC, Bordeaux JS, Chren MM, Sober AJ, Tegeler C, Bhushan R, Begolka WS.

J Am Acad Dermatol. 2015 Apr;72(4):717-23. doi: 10.1016/j.jaad.2015.01.025. Epub 2015 Feb 16. Review.

PMID:
25698455
32.

Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.

Wehner MR, Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Chren MM.

JAMA Dermatol. 2015 Apr;151(4):382-8. doi: 10.1001/jamadermatol.2014.3307.

PMID:
25588079
33.

Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16.

He Z, Lu C, Chren MM, Zhang Z, Li Y, Ni X, Buchtel V HA, Ryan PF, Li GZ.

Health Qual Life Outcomes. 2014 Dec 24;12:190. doi: 10.1186/s12955-014-0190-4.

34.

Patient-reported outcomes of electrodessication and curettage for treatment of nonmelanoma skin cancer.

Galles E, Parvataneni R, Stuart SE, Linos E, Grewal S, Chren MM.

J Am Acad Dermatol. 2014 Nov;71(5):1026-8. doi: 10.1016/j.jaad.2014.06.038. Epub 2014 Oct 15. No abstract available.

35.

Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy.

Linos E, Schroeder SA, Chren MM.

JAMA. 2014 Sep 10;312(10):997-8. doi: 10.1001/jama.2014.9655. No abstract available.

PMID:
25203077
36.

The good, the bad, and the ugly of free drug samples.

Katz KA, Reid EE, Chren MM.

JAMA Dermatol. 2014 Nov;150(11):1238. doi: 10.1001/jamadermatol.2014.1815. No abstract available.

PMID:
25188905
37.

Twitter: an opportunity for public health campaigns.

Wehner MR, Chren MM, Shive ML, Resneck JS Jr, Pagoto S, Seidenberg AB, Linos E.

Lancet. 2014 Jul 12;384(9938):131-2. doi: 10.1016/S0140-6736(14)61161-2. No abstract available.

PMID:
25016994
38.

Self-reported pigmentary phenotypes and race are significant but incomplete predictors of Fitzpatrick skin phototype in an ethnically diverse population.

He SY, McCulloch CE, Boscardin WJ, Chren MM, Linos E, Arron ST.

J Am Acad Dermatol. 2014 Oct;71(4):731-7. doi: 10.1016/j.jaad.2014.05.023. Epub 2014 Jun 11.

39.

Drug samples in dermatology: out of the closet, into the dustbin.

Katz KA, Reid EE, Chren MM.

JAMA Dermatol. 2014 May;150(5):483-5. doi: 10.1001/jamadermatol.2013.9711. No abstract available.

40.

International prevalence of indoor tanning: a systematic review and meta-analysis.

Wehner MR, Chren MM, Nameth D, Choudhry A, Gaskins M, Nead KT, Boscardin WJ, Linos E.

JAMA Dermatol. 2014 Apr;150(4):390-400. doi: 10.1001/jamadermatol.2013.6896. Review. Erratum in: JAMA Dermatol. 2014 May;150(5):577.

41.

Treatment of nonmelanoma skin cancer--reply.

Linos E, Landefeld CS, Chren MM.

JAMA Intern Med. 2013 Dec 9-23;173(22):2097. doi: 10.1001/jamainternmed.2013.10388. No abstract available.

PMID:
24322472
42.

Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires.

Mathias SD, Chren MM, Colwell HH, Yim YM, Reyes C, Chen DM, Fosko SW.

JAMA Dermatol. 2014 Feb;150(2):169-76. doi: 10.1001/jamadermatol.2013.5870.

PMID:
24285085
43.

Response to Rogers et al.

Chren MM.

J Invest Dermatol. 2014 Apr;134(4):1135-1136. doi: 10.1038/jid.2013.450. Epub 2013 Nov 12. No abstract available.

44.

Itch as a patient-reported symptom in ambulatory care visits in the United States.

Shive M, Linos E, Berger T, Wehner M, Chren MM.

J Am Acad Dermatol. 2013 Oct;69(4):550-6. doi: 10.1016/j.jaad.2013.05.029. Epub 2013 Jul 16.

45.

Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer.

Linos E, Parvataneni R, Stuart SE, Boscardin WJ, Landefeld CS, Chren MM.

JAMA Intern Med. 2013 Jun 10;173(11):1006-12. doi: 10.1001/jamainternmed.2013.639.

46.

Patient-reported problems after office procedures.

Linos E, Wehner MR, Frosch DL, Walter L, Chren MM.

JAMA Intern Med. 2013 Jul 8;173(13):1249-50. doi: 10.1001/jamainternmed.2013.1040. No abstract available.

47.

Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma.

Hamilton JR, Parvataneni R, Stuart SE, Chren MM.

JAMA Dermatol. 2013 May;149(5):616-8. doi: 10.1001/jamadermatol.2013.3339. No abstract available.

48.

Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus.

Hausauer AK, Maurer T, Leslie KS, Parvataneni R, Stuart SE, Chren MM.

JAMA Dermatol. 2013 Feb;149(2):239-41. doi: 10.1001/2013.jamadermatol.245. No abstract available.

49.

Effect of store and forward teledermatology on quality of life: a randomized controlled trial.

Whited JD, Warshaw EM, Edison KE, Kapur K, Thottapurathu L, Raju S, Cook B, Engasser H, Pullen S, Parks P, Sindowski T, Motyka D, Brown R, Moritz TE, Datta SK, Chren MM, Marty L, Reda DJ.

JAMA Dermatol. 2013 May;149(5):584-91. doi: 10.1001/2013.jamadermatol.380.

50.

Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.

Chren MM, Linos E, Torres JS, Stuart SE, Parvataneni R, Boscardin WJ.

J Invest Dermatol. 2013 May;133(5):1188-96. doi: 10.1038/jid.2012.403. Epub 2012 Nov 29.

Supplemental Content

Loading ...
Support Center